Search

Search Constraints

You searched for: Author/Creator Willi, Steven

Search Results

1. Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial. Issue 3 (March 2023)

2. Eligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D Clinic Registry. Issue 8 (10th October 2018)

3. Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Issue 8 (August 2021)

4. Longitudinal trajectories of BMI z‐score: an international comparison of 11, 513 Australian, American and German/Austrian/Luxembourgian youth with type 1 diabetes. Issue 2 (5th November 2019)

5. Peak cortisol response to corticotropin-releasing hormone is associated with age and body size in children referred for clinical testing: a retrospective review. (December 2015)

6. Vitamin D status in youth with type 1 and type 2 diabetes enrolled in the Pediatric Diabetes Consortium (PDC) is not worse than in youth without diabetes. Issue 8 (26th November 2015)